Clinical value of 12-lead electrocardiogram after successful reperfusion therapy for acute myocardial infarction

Lancet

Volumn 350, Issue 9078, 1997, Pages 615-619

  Van 'T Hof, Arnoud W J ^a   Liem, Aylee ^a   De Boer, Menko Jan ^a   Zijlstra, Felix ^a  

^a HOSPITAL DE WEEZENLANDEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

LACTATE DEHYDROGENASE;

ADULT; AGED; ARTICLE; CORONARY ARTERY DILATATION; ELECTROCARDIOGRAM; ENZYME ACTIVITY; FEMALE; HEART EJECTION FRACTION; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE REPERFUSION; HUMAN; MAJOR CLINICAL STUDY; MALE; METHODOLOGY; MORTALITY; PRIORITY JOURNAL; RISK ASSESSMENT; ST SEGMENT ELEVATION; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 0343035610     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(96)07120-6     Document Type: Article

References (32)

1. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 1994; 343: 311-22.
2. The GUSTO Angiographic Investigators. The effect of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival, after acute myocardial infarction. N Engl J Med 1993; 329: 1615-22.
3. Rentrop KP. Restoration of anterograde flow in acute myocardial infarction, the first 15 years. J Am Coll Cardiol 1995; 25 (suppl): 1S-2S.
4. Zijlstra F, de Boer MJ, Hoorntje JCA, Reiffers S, Reiber JHC, Suryapranata H. A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. N Engl J Med 1993; 328: 680-84.
5. Grines CL, Browne KF, Marco J, et al, for the Primary Angioplasty on Myocardial Infarction Study Group. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. N Engl J Med 1993; 328: 673-79.
6. de Boer MJ, Suryapranata H, Hoorntje JCA, et al. Limitation of infarct size and preservation of left ventricular function after primary coronary angioplasty compared with intravenous steptokinase in acute myocardial infarction. Circulation 1994; 90: 753-61.
7. de Boer MH, Reiber JHC, Suryapranata H, van den Brand MJBM, Hoorntje JCA, Zijlstra F. Angiographic findings and catheterisation laboratory events in patients with primary coronary angioplasty or streptokinase therapy for acute myocardial infarction. Eur Heart J 1995;16: 1347-55.
8. The EPIC investigators. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N Engl J Med 1994; 330: 956-61.
9. Wong PHC, Wong CM. Intracoronary stenting in acute myocardial infarction. Cathet Cardiovasc Diagn 1994; 33: 39-45.
10. Ohman EM, George BS, White CJ, et al. Use of aortic counterpulsation to improve sustained coronary patency during acute myocardial infarction: results of a randomised trial. Circulation 1994; 90: 792-99.
11. Schröder R, Dissman R, Bruggemann T, et al. Extent of early ST segment elevation resolution: a simple but strong predictor of outcome in patients with acute myocardial infarction. J Am Coll Cardiol 1994; 24: 384-91.
12. Barbash GI, Roth A, Hod H, et al. Rapid resolution of ST elevation and prediction of clinical outcome in patients undergoing thrombolysis with alteplase (recombinant tissue-type plasminogen activator): results of the Israeli Study of early intervention in myocardial infarction. Br Heart J 1990; 64: 241-47.
13. van der Laarse A, Vermeer F, Hermens WT, et al. Effects of intracoronary streptokinase on infarct size estimated from cumulative enzyme release and on enzyme release rate: a randomised trial of 533 patients with acute myocardial infarction. Am Heart J 1986; 112: 672-81.
14. de Zwaan C, Willems GM, Vermeer F, et al. Enzyme tests in the evaluation of thrombolysis in acute myocardial infarction. Br Heart J 1988; 59: 175-83.
15. Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-81.
16. Cox DR. Regression models and life tables. J R Stat Soc 1972; 34: 187-200.
17. Schlesselman JJ. Case-control studies. New York: Oxford Press, 1982: 203-06.
18. Klootwijk P, Langer A, Meij S, et al. Non-invasive prediction of reperfusion and coronary artery patency by continuous ST segment monitoring in the GUSTO-I trial. Eur Heart J 1996; 17: 689-98.
19. Clemmensen P, Ohman M, Sevilla DC, et al. Changes in standard electro cardiographic ST-segment elevation predictive of successful reperfusion in acute myocardial infarction. Am J Cardiol 1990; 66: 1407-11.
20. Califf RM, O'Neill W, Stack R, et al. Failure of simple clinical measurements to predict perfusion status after intravenous thrombolysis. Ann Intern Med 1988; 108: 658-62.
21. Ito H, Tomooka T, Sakai N, et al. Lack of myocardial perfusion immediately after successful thrombolysis: a predictor of poor recovery of left ventricular function in anterior myocardial infarction. Circulation 1992; 85: 1699-705.
22. Ito H, Maruyama A, Iwakura K, et al. Clinical implications of the "no reflow" phenomenon. Circulation 1996; 93: 223-28.
23. Iliceto S, Galiuto L, Marchese A, et al. Analysis of microvascular integrity, contractile reserve, and myocardial viability after acute myocardial infarction by dobutamine echocardiography and myocardial contrast echocardiography. Am J Cardiol 1996; 77: 441-45.
24. Hashimoto A, Nakata T, Tsuchihashi K, Tanaka S, Fujimori K, Limura O. Postischemic functional recovery and BMIPP uptake after primary percutaneous transluminal coronary angioplasty in acute myocardial infarction. Am J Cardiol 1996; 77: 25-30.
25. Maes A, Van de Werf F, Nuyts J, Bormans G, Desmet W, Mortelmans L. Impaired myocardial tissue perfusion early after successful thrombolysis: impact on myocardial flow, metabolism, and function at late follow-up. Circulation 1995; 92: 2072-78.
26. Hasche ET, Fernandes C, Freedman SB, Jeremy RW. Relation between ischemia time, infarct size, and left ventricular function in humans. Circulation 1995; 92: 710-19.
27. Raitt MH, Maynard C, Wagner GS, Cerqueirra MD, Selvester RH, Weaver WD. Relation between symptom duration before thrombolytic therapy and final myocardial infarct size. Circulation 1996; 93: 48-53.
28. Hermens WTH, Willems GM, Nijssen KM, Simoons ML. Effect of thrombolytic treatment delay on myocardial infarct size. Lancet 1992; 340: 1297.
29. Ferrari R. Metabolic disturbances during myocardial ischemia and reperfusion. Am J Cardiol 1995; 76: 17B-24B.
30. Mauri F, Maggioni AP, Franzosi MP, et al. A simple electro cardiographic predictor of the outcome of patients with acute myocardial infarction treated with a thrombolytic agent: a GISSI-2-derived analysis. J Am Coll Cardiol 1994; 24: 600-07.
31. Weaver WD, Cerqueira M, Hallstrom AP, et al. Pre-hospital-initiated vs hospital-initiated thrombolytic therapy: the myocardial infarction triage and intervention trial. JAMA 1993; 270: 1211-16.
32. GREAT Group. Feasibility, safety, and efficacy of domiciliary thrombolysis by general practitioners: Grampian region early anistreplase trial. BMJ 1992; 305: 548-53.